ORIONS Money Stocks

[AugustaFriends]

SPEX $3.50 target in 2011 by Zack's + 11 January Finance Conferences + Big announcement from FDA due in 1st quarter 2011 on Phase 3 Resulys.

January 11, 2011 Spherix to Present at Two Upcoming Prominent Finance Conferences

President, Dr. Robert Lodder, will be presenting at both OneMedForum SF 2011 and Biotech Showcase 2011.
http://finance.yahoo.com/news/Spherix-to-Present-at-Two-prnews-915656044.html?x=0&.v=1



To give you an outside opinion, Zack’s has a target price of $3.50 on them and an optimistic view of the potential for their Phase 3 data with D-tagatose; we encourage anyone interested in SPEX to read it to further their due diligence.

http://www.chasingthealpha.com/2010/09/spex-phase-3-results-coming-soonreport.html